Cardiolyse Predictive Cardiac Analytics Cloud Platform Won the EXECInsurtech Startup Pitching Competition

The patented technology for cardiac and fatigue risks monitoring was named the most promising for the insurance sector.

Cardiolyse (https://cardiolyse.com/) was selected to pitch at EXECInsurtech and won the startup pitching competition at Europe’s prime event for insurance technology and innovation in Cologne, Germany. This year the event gathered more than 300 insurtech advocates and 15 selected startups that fought for the opportunity to win the accelerator participation for the seed-stage projects or a business trip to London, Berlin, New York, or Tel Aviv for the early-stage companies.

Cardiolyse won the early stage prize and will now decide in which city to focus their later endeavors. The company presented its clinically-validated fatigue-tracking solution for the critical safety job performers in the transport industry and among medical staff, lone workers, etc. where severe tiredness levels increase the risk of error or accident, endangering other people’s lives. Analyzing the person’s ECG and HRV in real-time, Cardiolyse automatically interprets all the vital parameter values to detects abnormal fatigue levels, alerting both user and the control room on increased risk. “All the current cardiac risks and fatigue management solutions in transport, medical or aviation sectors, unfortunately, include only some manual lifestyle restrictions,'' commented Anna Starynska, founder and CEO at Cardiolyse. "We're glad to present the seamless digital cardiac analytics solution, that enables instant monitoring of the cardiac and fatigue-driven risks, helping predict and prevent further accidents for critical safety job performers, cutting down the liability insurance costs."

Starting its history in 2013, EXECInsurtech became one of the largest match-making platforms for insurers, tech investors and startups, uniting people globally and giving them an opportunity to drive business cooperation, discuss the latest insurtech trends and challenges, and altogether implement cooperation projects to improve the global insurance solutions and offerings. “We are thrilled to make our contribution to the growth of global insurtech community which is centered here, in Cologne,” commented Sebastian Pitzler, the InsurLab Germany managing director. “With the comprehensive solutions presented here, we hope to further strengthen the existing links between global insurance companies and work together on insurance industry digitalization.”

GE Health Innovation Village, 2 Kuortaneenkatu, Helsinki, Finland 00510

About Cardiolyse
Established in 2016, Cardiolyse is a cloud predictive cardiac analytics platform, that enables automatic electrocardiogram (ECG/EKG) interpretation for real-time remote heart health monitoring and delivers the personalized data-based middle term prognosis on dangerous heart events. The solution is CE-certified for automatic detection of 19 types of Arrhythmias with its patented algorithms, standing behind the Universal ECG Score calculation and the Personal Baseline development. It’s a device-agnostic B2B solution with the Universal SDK provided for fast and seamless integration with any leads number digital ECG device.
The ecosystem of integrated cardiovascular disease management and prevention consists of the web dashboard and user-friendly Android and iOS applications with both doctor's and patient interfaces.
The company’s headquarters is in Helsinki, Finland, with offices in London, UK and Kyiv, Ukraine.

https://cardiolyse.com/
marketing@cardiolyse.com

About InsurLabGermany
InsurLab Germany is the largest networking platform in Germany connecting insurance companies, corporations, and Start-ups. Through different activities, they promote active cooperation between founders and corporates and help to build up a digital ecosystem around the German insurance industry.

https://www.insurlab-germany.com/en/insurlab/

This release was published on openPR.